Status:
UNKNOWN
Identification of Molecular Marker of Coagulase-negative Staphylococci for the Diagnosis of Prosthetic Joint Infections
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Prosthetic Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
One of the major causes of prosthetic joint failure is infection. Recently, coagulase-negative Staphylococci (CoNS) have been identified as emergent, nosocomial pathogens involved in subclinical prost...
Detailed Description
Task 1.1: Synovial fluids will be collected from 60 patients referred to IRCCS Galeazzi Orthopedic Institute for the revision of a septic prosthesis and from 40 patients undergoing revision due to ase...
Eligibility Criteria
Inclusion
- ≥ 18 years old patients
- Patients subjected to a revision of the articular prosthesis due to bacterial infection mediated by coagulase-negative Staphylococci (CoNS) or to an aseptic failure of the implant
- Collection of a sufficient volume of synovial fluid
- Patient consent by signing an informed consent form
Exclusion
- Patients not fulfilling the inclusion criteria
- Collection of a hemolytic sample
Key Trial Info
Start Date :
October 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 14 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04661345
Start Date
October 14 2020
End Date
October 14 2023
Last Update
December 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy, 20161